MR编号 | SE/H/2040/001 |
---|
药品名称 | Ryaltris |
---|
活性成分 | - mometasone furoate 25.0 µg
- olopatadine 600.0 µg
|
---|
剂型 | Nasal spray, suspension |
---|
上市许可持有人 | Glenmark Pharmaceuticals s.r.o., Czech Republic |
---|
参考成员国 - 产品名称 | Sweden (SE) |
---|
互认成员国 - 产品名称 | - Norway (NO)
Ryaltris - Finland (FI)
- Poland (PL)
Ryaltris Nasal Spray - Germany (DE)
Ryaltris 25 Mikrogramm/600 Mikrogramm pro Sprühstoß Nasenspray, Suspension - Czechia (CZ)
RYALTRIS Nasal Spray - Denmark (DK)
- Romania (RO)
RYALTRIS Nasal Spray 600 micrograms/25 micrograms per actuation - Belgium (BE)
Ryaltris 25 microgrammes/pulvérisation + 600 microgrammes/ pulvérisation, suspension pour pulvérisation nasale - Slovakia (SK)
- Netherlands (NL)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
RYALTRIS 25 Mikrogramm/600 Mikrogramm pro Sprühstoß Nasenspray, Suspension - France (FR)
- Spain (ES)
- Italy (IT)
|
---|
许可日期 | 2021/04/13 |
---|
最近更新日期 | 2024/07/01 |
---|
药物ATC编码 | - R01AD59 mometasone, combinations
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|
|
---|